Myasthenia Gravis Disease Market The surging cases of neuromuscular disorders are estimated to favor the market growth globally. Myasthenia gravis is referred to as a neuromuscular disorder which results in the skeletal muscles to weaken. The Myasthenia Gravis Disease Market Share is projected to reach USD 1.97 billion by 2032 at 7.9% CAGR during the forecast period 2023-2032. The disease...